Schwartz EL - Search Results

1

Antiangiogenic and antitumor activity of 6-(2-aminoethyl)amino-5-chlorouracil, a novel small-molecule inhibitor of thymidine phosphorylase, in combination with the vascular endothelial growth factor-trap.

Lu H, Klein RS, Schwartz EL. Lu H, et al. Among authors: schwartz el. Clin Cancer Res. 2009 Aug 15;15(16):5136-44. doi: 10.1158/1078-0432.CCR-08-3203. Epub 2009 Aug 11. Clin Cancer Res. 2009. PMID: 19671868 Free PMC article.

2

Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies: a review.

Wadler S, Schwartz EL. Wadler S, et al. Among authors: schwartz el. Cancer Res. 1990 Jun 15;50(12):3473-86. Cancer Res. 1990. PMID: 1692761 Review.

3

Interaction of fluorouracil and interferon in human colon cancer cell lines: cytotoxic and cytokinetic effects.

Wadler S, Wersto R, Weinberg V, Thompson D, Schwartz EL. Wadler S, et al. Among authors: schwartz el. Cancer Res. 1990 Sep 15;50(18):5735-9. Cancer Res. 1990. PMID: 1697499

4

Fluorouracil and recombinant alfa-2a-interferon: an active regimen against advanced colorectal carcinoma.

Wadler S, Schwartz EL, Goldman M, Lyver A, Rader M, Zimmerman M, Itri L, Weinberg V, Wiernik PH. Wadler S, et al. Among authors: schwartz el. J Clin Oncol. 1989 Dec;7(12):1769-75. doi: 10.1200/JCO.1989.7.12.1769. J Clin Oncol. 1989. PMID: 2585018

5

Enhanced mitogenic responsiveness to granulocyte-macrophage colony-stimulating factor in HL-60 promyelocytic leukemia cells upon induction of differentiation.

Schwartz EL, Maher AM. Schwartz EL, et al. Cancer Res. 1988 May 15;48(10):2683-7. Cancer Res. 1988. PMID: 2834046

6

5-Ethoxy-2'-deoxyuridine, a novel substrate for thymidine phosphorylase, potentiates the antitumor activity of 5-fluorouracil when used in combination with interferon, an inducer of thymidine phosphorylase expression.

Schwartz EL, Baptiste N, Megati S, Wadler S, Otter BA. Schwartz EL, et al. Cancer Res. 1995 Aug 15;55(16):3543-50. Cancer Res. 1995. PMID: 7627962

7

Thymidine phosphorylase mediates the sensitivity of human colon carcinoma cells to 5-fluorouracil.

Schwartz EL, Baptiste N, Wadler S, Makower D. Schwartz EL, et al. J Biol Chem. 1995 Aug 11;270(32):19073-7. doi: 10.1074/jbc.270.32.19073. J Biol Chem. 1995. PMID: 7642571 Free article.

8

Potentiation of the antitumor activity of 5-fluorouracil in colon carcinoma cells by the combination of interferon and deoxyribonucleosides results from complementary effects on thymidine phosphorylase.

Schwartz EL, Baptiste N, O'Connor CJ, Wadler S, Otter BA. Schwartz EL, et al. Cancer Res. 1994 Mar 15;54(6):1472-8. Cancer Res. 1994. PMID: 8137250

9

Phase I trial of cyclophosphamide, doxorubicin, and 5-fluorouracil plus interferon-alpha 2b in patients with advanced breast cancer.

Sparano JA, Wadler S, Liebes L, Robert NJ, Schwartz EL, Dutcher JP. Sparano JA, et al. Among authors: schwartz el. Cancer Res. 1993 Aug 1;53(15):3509-12. Cancer Res. 1993. PMID: 8339255 Clinical Trial.

10

Dimethyl sulfoxide inhibits the binding of granulocyte/macrophage colony-stimulating factor and insulin to their receptors on human leukemia cells.

Schwartz EL, Chamberlin H, Ravichander P, Whitbread JA. Schwartz EL, et al. Cancer Res. 1993 Mar 1;53(5):1142-8. Cancer Res. 1993. PMID: 8439959

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

140 results

Search Page

Filters